HEMOGENYX PHARMACEUTICALS PLC O吧
排序：
评论时间
  • 评论时间
  • 发帖时间
阅读评论标题 作者 最后更新
17 0 公告 Invitation to Participate at DCNY Summit HEMOGENYX PHARMA资讯 09-11 14:22
19 0 公告 Manufacturing Partnership with Made Scientific HEMOGENYX PHARMA资讯 09-08 14:31
25 0 公告 Exercise of Warrants and Issue of Equity HEMOGENYX PHARMA资讯 09-05 14:21
22 0 公告 Exercise of Warrants and Issue of Equity HEMOGENYX PHARMA资讯 09-03 21:00
28 0 公告 Issue of convertible loan notes HEMOGENYX PHARMA资讯 09-01 22:11
23 0 公告 Result of Audit Tender HEMOGENYX PHARMA资讯 08-29 14:20
22 0 公告 Hemogenyx raises ￡570,000 and Director's Dealing HEMOGENYX PHARMA资讯 08-26 18:47
19 0 公告 Third Patient Treated with HG-CT-1 CAR-T Therapy HEMOGENYX PHARMA资讯 08-15 14:16
23 0 公告 Total Voting Rights HEMOGENYX PHARMA资讯 07-31 14:27
31 0 公告 Placing to Raise ￡250,000 and Director’s Dealing HEMOGENYX PHARMA资讯 07-29 15:04
28 0 公告 Hemogenyx Awarded Grant HEMOGENYX PHARMA资讯 07-16 14:22
20 0 公告 Total Voting Rights HEMOGENYX PHARMA资讯 06-30 14:15
25 0 公告 Clearance to Proceed with Pediatric Expansion HEMOGENYX PHARMA资讯 06-17 14:16
39 0 公告 Placing to Raise ￡451,250 and Director’s Dealing HEMOGENYX PHARMA资讯 06-03 21:05
38 0 公告 Second Patient Passes Initial Safety Tests HEMOGENYX PHARMA资讯 06-03 14:29
36 0 公告 Total Voting Rights HEMOGENYX PHARMA资讯 05-30 22:18
44 0 公告 Result of AGM HEMOGENYX PHARMA资讯 05-29 21:09
29 0 公告 Pediatric Amendment to Clinical Protocol HEMOGENYX PHARMA资讯 05-14 14:19
34 0 公告 AGM Correction HEMOGENYX PHARMA资讯 05-13 14:15
34 0 公告 Placing to Raise ￡451,250 and Director’s Dealing HEMOGENYX PHARMA资讯 05-08 14:20
65 0 公告 Notice of AGM HEMOGENYX PHARMA资讯 05-02 23:26
45 0 公告 Second Patient Treated with HG-CT-1 CAR-T Therapy HEMOGENYX PHARMA资讯 05-02 14:14
38 0 公告 Final Results HEMOGENYX PHARMA资讯 04-28 14:14
36 0 公告 FDA Annual Report HEMOGENYX PHARMA资讯 04-03 15:10
34 0 公告 Total Voting Rights HEMOGENYX PHARMA资讯 03-31 14:22
25 0 公告 First Patient Safety HEMOGENYX PHARMA资讯 03-24 15:17
32 0 公告 Recruitment of Second Patient for Clinical Trials HEMOGENYX PHARMA资讯 03-17 15:20
36 0 公告 Conversion of convertible loan notes HEMOGENYX PHARMA资讯 03-13 23:13
33 0 公告 Institutional investment HEMOGENYX PHARMA资讯 03-11 15:25
33 0 公告 First-in-Human Treatment with HG-CT-1 HEMOGENYX PHARMA资讯 02-24 15:18
43 0 公告 Issue of convertible loan notes HEMOGENYX PHARMA资讯 02-20 00:54
59 0 公告 Total Voting Rights HEMOGENYX PHARMA资讯 01-31 17:38
47 0 公告 Placing to raise ￡340,000 HEMOGENYX PHARMA资讯 01-08 15:12
57 0 公告 Change of Company Secretary and Registered Office HEMOGENYX PHARMA资讯 01-02 15:18
43 0 公告 Total Voting Rights HEMOGENYX PHARMA资讯 12-31 15:09
64 0 公告 Opening of First Clinical Site HEMOGENYX PHARMA资讯 12-30 15:09
76 0 公告 Ultrafast CAR-T Manufacturing HEMOGENYX PHARMA资讯 12-19 15:16
64 0 公告 Admission of New Ordinary Shares and New ISIN HEMOGENYX PHARMA资讯 12-11 00:13
65 0 公告 Result of Extraordinary General Meeting HEMOGENYX PHARMA资讯 12-09 21:33
56 0 公告 Site Initiation Visit Completed HEMOGENYX PHARMA资讯 12-09 15:09
61 0 公告 CBR Macrophage Delivery Update HEMOGENYX PHARMA资讯 12-06 15:12
68 0 公告 Total Voting Rights HEMOGENYX PHARMA资讯 11-29 15:14
63 0 公告 Notice of Extraordinary General Meeting HEMOGENYX PHARMA资讯 11-22 20:51
57 0 公告 IRB Approval for Phase I Clinical Trial HEMOGENYX PHARMA资讯 11-22 15:16
73 0 公告 Institutional Investment HEMOGENYX PHARMA资讯 11-11 15:15
65 0 公告 Schedule for Phase I Clinical Trial Opening HEMOGENYX PHARMA资讯 10-30 15:16
72 0 公告 Strategic Investment from Prevail Partners, LLC HEMOGENYX PHARMA资讯 10-02 18:21
68 0 公告 Half-year Report HEMOGENYX PHARMA资讯 09-27 14:16
62 0 公告 FLT3 Assay Ready for Phase I Trials at MD Anderson HEMOGENYX PHARMA资讯 09-09 14:16
53 0 公告 CDX Development Update HEMOGENYX PHARMA资讯 09-02 14:16
55 0 公告 Presentation at CBD S&T Conference HEMOGENYX PHARMA资讯 08-28 15:07
54 0 公告 Macrophage-Directed Therapies Summit Presentation HEMOGENYX PHARMA资讯 07-29 14:08
75 0 公告 Result of Annual General Meeting HEMOGENYX PHARMA资讯 06-28 00:48
74 0 公告 Operations Update HEMOGENYX PHARMA资讯 06-17 15:10
63 0 公告 Posting of Annual Report & Notice of AGM HEMOGENYX PHARMA资讯 06-03 15:09
52 0 公告 Final Results HEMOGENYX PHARMA资讯 04-25 15:08
55 0 公告 Total Voting Rights HEMOGENYX PHARMA资讯 03-28 16:04
75 0 公告 Placing to Raise US$4.2 million HEMOGENYX PHARMA资讯 02-29 16:09
94 0 公告 CBR Brain Delivery HEMOGENYX PHARMA资讯 02-16 16:08
80 0 公告 CBR Intranasal Delivery HEMOGENYX PHARMA资讯 02-14 16:08
93 0 公告 FDA Consents to Phase I Trials of HEMO-CAR-T HEMOGENYX PHARMA资讯 02-09 16:09
69 0 公告 Approval and Issuance of U.S. Conditioning Patent HEMOGENYX PHARMA资讯 02-02 16:09
73 0 公告 Submission of Complete Response to Clinical Hold HEMOGENYX PHARMA资讯 01-16 16:10
80 0 公告 HEMO-CAR-T Process Qualification Run Completed HEMOGENYX PHARMA资讯 01-08 16:09
71 0 公告 Placing to Raise ￡534,375 HEMOGENYX PHARMA资讯 11-28 21:27
73 0 公告 CBR Expanded to Treatment of Cancer HEMOGENYX PHARMA资讯 11-27 16:08
66 0 公告 Lentivirus Re-manufacturing Completed HEMOGENYX PHARMA资讯 11-15 16:10
75 0 公告 Total Voting Rights HEMOGENYX PHARMA资讯 10-31 16:10
81 0 公告 Half-year Report HEMOGENYX PHARMA资讯 09-28 20:39
67 0 公告 Strategic Investment from Prevail Partners, LLC HEMOGENYX PHARMA资讯 09-18 15:48
75 0 公告 Clinical Hold Lift Plan is accepted by FDA HEMOGENYX PHARMA资讯 09-14 15:11
83 0 公告 CBR Patent Application Update HEMOGENYX PHARMA资讯 09-09 00:22
100 0 公告 Full FDA Review for HEMO-CAR-T IND HEMOGENYX PHARMA资讯 07-10 15:05
86 0 公告 Result of Annual General Meeting HEMOGENYX PHARMA资讯 07-01 00:13
108 0 公告 Posting of Annual Report & Notice of AGM HEMOGENYX PHARMA资讯 06-02 22:24
117 0 公告 Clinical Hold on IND for HEMO-CAR-T HEMOGENYX PHARMA资讯 06-02 19:38
97 0 公告 Submission of IND for HEMO-CAR-T HEMOGENYX PHARMA资讯 05-09 15:09
129 0 公告 Equity Incentive Pool Increase and Option Grant HEMOGENYX PHARMA资讯 04-28 18:19
103 0 公告 Final Results for the Year Ended 31 December 2022 HEMOGENYX PHARMA资讯 04-28 15:04
120 0 公告 HEMO-CAR-T Analytical Release Tests Completed HEMOGENYX PHARMA资讯 03-23 21:50
发表新主题
悬赏提问
帖子不见了！怎么办？   
   请登录 登录 | 5秒注册 作者： 退出 
温馨提示： 1.根据《证券法》规定，禁止编造、传播虚假信息或者误导性信息，扰乱证券市场；2.用户在本社区发表的所有资料、言论等仅代表个人观点，与本网站立场无关，不对您构成任何投资建议。用户应基于自己的独立判断，自行决定证券投资并承担相应风险。《东方财富社区管理规定》
东方财富

扫一扫下载APP
东方财富产品
证券交易
关注东方财富
天天基金

扫一扫下载APP
基金交易
关注天天基金
东方财富期货

扫一扫下载APP
期货交易
信息网络传播视听节目许可证：0908328号 经营证券期货业务许可证编号：913101046312860336 违法和不良信息举报:021-34289898 举报邮箱：jubao@eastmoney.com
沪ICP证:沪B2-20070217 网站备案号:沪ICP备05006054号-11 沪公网安备 31010402000120号 版权所有:东方财富网 意见与建议:021-54509966/952500
关于我们 广告服务 联系我们 诚聘英才 免责声明 法律声明 隐私保护 征稿启事 放心搜 友情链接